top of page
Photo of Thomas N. Wang, M.D.

Surgeon

Thomas N. Wang, M.D.

Thomas Wang, M.D., Ph.D., is a board-certified surgical oncologist with the Hoag Family Cancer Institute and the medical director of the Hoag Melanoma/Advanced Skin Cancer Program. Dr. Wang comes to Hoag after spending the previous 15 years at the University of Alabama at Birmingham (UAB), where he served as a Professor of Surgery at the UAB School of Medicine and Chief of Surgical Oncology for the Birmingham VA Medical Center. He is a recognized author and researcher and has published over 40 original manuscripts in peer- reviewed scientific journals and ten book chapters. He has presented his clinical and basic science research at multiple national and international meetings. Dr. Wang is a graduate of Brown University and attended the Lewis Katz School of Medicine at Temple University. He completed his general surgery residency training at Drexel University College of Medicine/Hahnemann University Hospital and his surgical oncology fellowship at the University of Texas M.D. Anderson Cancer Center. Dr. Wang’s clinical interests include melanoma, soft tissue sarcomas and endocrine surgery. Dr. Wang is an active member on multiple national surgical societies, including the Association for Academic Surgery, the Society of University Surgeons, the American Association of Endocrine Surgeons and the Society of Surgical Oncology. In addition, since 2007, he is a panel member in the National Comprehensive Cancer Network, developing guidelines for the treatment of thyroid cancer.

More Experts

Jeanne-Homer1.jpeg

Jeanne Homer

Genetics Conselour

april-ks-salama-md_edited_edited.jpg

Dr. April

Salama

Medical Oncology

kyleigh.png

Kyleigh Lipira

Non-Profit

Interview with Thomas N. Wang

12/2022

JUMP TO SECTION

youtube-icon-flat-red-play-button-logo-vector.png

01

(0:38 - 1:53)

Introduction

youtube-icon-flat-red-play-button-logo-vector.png

02

(1:55 - 4:00)

Hear about Dr. Wang consultation process and his philosophy of treating patients with melanoma

youtube-icon-flat-red-play-button-logo-vector.png

03

(4:01 - 7:07)

Surgical management for Stage I. Excellent survival outcome and importance of relieving fear.  Importance of ongoing surveillance.

youtube-icon-flat-red-play-button-logo-vector.png

04

(7:07 - 10:50)

Importance of accurate staging with Sentinel Lymph node biopsy. What is Sentinel lymph node?

youtube-icon-flat-red-play-button-logo-vector.png

05

(10:51 - 14:16)

What is the SLNB procedure? How is it performed? Common misconception

youtube-icon-flat-red-play-button-logo-vector.png

06

(14:16 - 22:16)

Which patients need SLNB? What is the criteria to perform SLNB? Criteria and scenario for not performing SLNB

youtube-icon-flat-red-play-button-logo-vector.png

07

(22:17 - 27:59)

What to do for a patient with a positive SLNB, stage III patient? What is complete Lymph Node dissection - its role in treating melanoma and associated side effects?

youtube-icon-flat-red-play-button-logo-vector.png

08

(28:00 - 30:56)

Role of surgery in stage IV disease

youtube-icon-flat-red-play-button-logo-vector.png

09

(30:56 - 33:26)

Melanoma Tumor Board at Hoag Family Cancer Institute

youtube-icon-flat-red-play-button-logo-vector.png

10

(33:27 - 35:08)

Conclusion. Words of wisdom and insipiration

bottom of page